With Dr. Joseph Rubinfeld joining the BOD, Amarant
Post# of 30025
Posted On: 11/17/2014 11:29:34 PM
With Dr. Joseph Rubinfeld joining the BOD, Amarantus now meets the Nasdaq uplist requirements for majority of board as Independent Directors.
Donald D. Huffman
Independent Director
Chairman of the Audit Committee
Robert L. Harris
Independent Director, Compliance Officer
Iain Ross
Independent Director
David A. Lowe, PhD
Gerald E. Commissiong
President & CEO
John W. Commissiong, PhD
Chief Scientific Officer
Donald D. Huffman
Independent Director
Chairman of the Audit Committee
Robert L. Harris
Independent Director, Compliance Officer
Iain Ross
Independent Director
David A. Lowe, PhD
Gerald E. Commissiong
President & CEO
John W. Commissiong, PhD
Chief Scientific Officer
(0)
(0)